Pub Date : 2026-03-01Epub Date: 2026-02-26DOI: 10.1016/j.rce.2026.502490
M. Colangeli , M. Palmas , P. Spinnato
{"title":"Un caso raro de linfangioma quístico del cuello en un paciente adulto","authors":"M. Colangeli , M. Palmas , P. Spinnato","doi":"10.1016/j.rce.2026.502490","DOIUrl":"10.1016/j.rce.2026.502490","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"226 3","pages":"Article 502490"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147429082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-17DOI: 10.1016/j.rce.2026.502483
P. Durán del Campo , G. Solano Iturri , B. Alonso Ortiz , J. Bertran Muñoz , A.M. Bravo Blanco , L. Briongos Figuero , C. Carrera García , A.D. Chacón Moreno , A. Blanco Portillo , J.M. Galván-Román , como miembros del Grupo de Trabajo de Bioética y Profesionalismo de la Sociedad Española de Medicina Interna
Objectives
To analyze the current situation of Healthcare Ethics Committees (HECs) in Spain, their composition and functions, as well as the implementation of Clinical Ethics Consultancy (CEC). Finally, to assess the involvement of internists in HECs.
Materials and methods
A cross-sectional descriptive study conducted through a self-administered online survey distributed between February and May 2025 to all identified HECs in the country.
Results
A total of 112 HECs (47.66%) out of the 235 accredited nationwide participated. The average number of members per committee was 16 (range: 6-29). The most represented professional profiles were nursing and medicine. In 99.1% of the committees, at least one member had postgraduate training in Bioethics. The most frequent range of meetings per year was between 7 and 12 (46.8%). Most HECs (91.1%) were involved in educational activities, and 58% had produced ethical documents. The majority reviewed between 1 and 5 cases annually (69.6%). The CEC role was established in 40.2% of HECs and in the process of implementation in 18.8%. Internists were present in 54% of HECs. In 65% of cases, the internist is part of the CEC.
Conclusions
HECs in Spain demonstrate significant involvement in educational activities and the development of ethical documents; however, they receive a relatively low number of annual consultations. CEC is gradually being integrated into the structure of HECs, which may enhance the management of ethical inquiries. Internists are members of more than half of the HECs and play a very active role in their operations.
{"title":"Situación actual y papel de los internistas en los comités de ética asistencial en España. Estudio PANACEAS","authors":"P. Durán del Campo , G. Solano Iturri , B. Alonso Ortiz , J. Bertran Muñoz , A.M. Bravo Blanco , L. Briongos Figuero , C. Carrera García , A.D. Chacón Moreno , A. Blanco Portillo , J.M. Galván-Román , como miembros del Grupo de Trabajo de Bioética y Profesionalismo de la Sociedad Española de Medicina Interna","doi":"10.1016/j.rce.2026.502483","DOIUrl":"10.1016/j.rce.2026.502483","url":null,"abstract":"<div><h3>Objectives</h3><div>To analyze the current situation of Healthcare Ethics Committees (HECs) in Spain, their composition and functions, as well as the implementation of Clinical Ethics Consultancy (CEC). Finally, to assess the involvement of internists in HECs.</div></div><div><h3>Materials and methods</h3><div>A cross-sectional descriptive study conducted through a self-administered online survey distributed between February and May 2025 to all identified HECs in the country.</div></div><div><h3>Results</h3><div>A total of 112 HECs (47.66%) out of the 235 accredited nationwide participated. The average number of members per committee was 16 (range: 6-29). The most represented professional profiles were nursing and medicine. In 99.1% of the committees, at least one member had postgraduate training in Bioethics. The most frequent range of meetings per year was between 7 and 12 (46.8%). Most HECs (91.1%) were involved in educational activities, and 58% had produced ethical documents. The majority reviewed between 1 and 5 cases annually (69.6%). The CEC role was established in 40.2% of HECs and in the process of implementation in 18.8%. Internists were present in 54% of HECs. In 65% of cases, the internist is part of the CEC.</div></div><div><h3>Conclusions</h3><div>HECs in Spain demonstrate significant involvement in educational activities and the development of ethical documents; however, they receive a relatively low number of annual consultations. CEC is gradually being integrated into the structure of HECs, which may enhance the management of ethical inquiries. Internists are members of more than half of the HECs and play a very active role in their operations.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"226 3","pages":"Article 502483"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147428019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-24DOI: 10.1016/j.rce.2026.502487
A. Haro , J. Jacob , X. Rossello , A. Alquézar-Arbe , P. Llorens , Ò. Miró , en representación del grupo Icasemes
Introduction
Baseline treatment with beta-blockers (BB) and/or renin-angiotensin system inhibitors (RASi) has been extensively studied in the context of heart failure, given its fundamental role in modulating the neurohormonal axis and improving survival.
Objective
To investigate whether there is an association between receiving baseline treatment with BB or RASi, either alone or in combination, and the short-term prognosis of an episode of acute heart failure (AHF).
Method
Patients from the EAHFE registry (Epidemiology of Acute Heart Failure in Spanish Emergency Departments) were analyzed. This is a multicenter, prospective, multipurpose registry that collects all AHF episodes presenting to participating hospital emergency departments over a period of 1 to 2 months between 2007 and 2018. The primary outcome variable investigated was in-hospital all-cause mortality during the emergency departments stay or hospitalization. Adjusted analyses were conducted using multiple logistic regression and multiple imputation to control for potential confounding factors.
Results
The study included a total of 17,916 episodes of AHF. A total of 26.2% of patients did not receive treatment with either BB or RASi, constituting the reference group. Overall, 17.8% of patients received BB only, 30.4% were treated exclusively with RASi, and 25.7% received a combination of both drugs. The mean age of the patients was 80.4 years (standard deviation 10.2 years), and 55.7% were women. In-hospital mortality was 7.3%. After multivariable adjustment, a significant association with lower mortality was found for treatment with BB alone (odds ratio [OR] = 0.826, 95% confidence interval [CI]: 0.685-0.996), OR = 0.709 (95%CI: 0.600-0.837) RASi alone and for combined treatment with RASi and BB (OR = 0.699, 95%CI: 0.580-0.843). In the adjusted model with multiple imputation, the results remained significant.
Conclusions
In patients with an episode of AHF, baseline treatment with BB, RASi, or both is associated with lower all-cause mortality. This association is strongest in the group of patients receiving both treatments combined, and the results remain significant after multivariate adjustment.
{"title":"Tratamiento basal con betabloqueantes e inhibidores del sistema renina angiotensina y su asociación con eventos adversos en insuficiencia cardíaca aguda","authors":"A. Haro , J. Jacob , X. Rossello , A. Alquézar-Arbe , P. Llorens , Ò. Miró , en representación del grupo Icasemes","doi":"10.1016/j.rce.2026.502487","DOIUrl":"10.1016/j.rce.2026.502487","url":null,"abstract":"<div><h3>Introduction</h3><div>Baseline treatment with beta-blockers (BB) and/or renin-angiotensin system inhibitors (RASi) has been extensively studied in the context of heart failure, given its fundamental role in modulating the neurohormonal axis and improving survival.</div></div><div><h3>Objective</h3><div>To investigate whether there is an association between receiving baseline treatment with BB or RASi, either alone or in combination, and the short-term prognosis of an episode of acute heart failure (AHF).</div></div><div><h3>Method</h3><div>Patients from the EAHFE registry (Epidemiology of Acute Heart Failure in Spanish Emergency Departments) were analyzed. This is a multicenter, prospective, multipurpose registry that collects all AHF episodes presenting to participating hospital emergency departments over a period of 1 to 2 months between 2007 and 2018. The primary outcome variable investigated was in-hospital all-cause mortality during the emergency departments stay or hospitalization. Adjusted analyses were conducted using multiple logistic regression and multiple imputation to control for potential confounding factors.</div></div><div><h3>Results</h3><div>The study included a total of 17,916 episodes of AHF. A total of 26.2% of patients did not receive treatment with either BB or RASi, constituting the reference group. Overall, 17.8% of patients received BB only, 30.4% were treated exclusively with RASi, and 25.7% received a combination of both drugs. The mean age of the patients was 80.4 years (standard deviation 10.2 years), and 55.7% were women. In-hospital mortality was 7.3%. After multivariable adjustment, a significant association with lower mortality was found for treatment with BB alone (odds ratio [OR]<!--> <!-->=<!--> <!-->0.826, 95% confidence interval [CI]: 0.685-0.996), OR<!--> <!-->=<!--> <!-->0.709 (95%CI: 0.600-0.837) RASi alone and for combined treatment with RASi and BB (OR<!--> <!-->=<!--> <!-->0.699, 95%CI: 0.580-0.843). In the adjusted model with multiple imputation, the results remained significant.</div></div><div><h3>Conclusions</h3><div>In patients with an episode of AHF, baseline treatment with BB, RASi, or both is associated with lower all-cause mortality. This association is strongest in the group of patients receiving both treatments combined, and the results remain significant after multivariate adjustment.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"226 3","pages":"Article 502487"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147429078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-23DOI: 10.1016/j.rce.2026.502470
P. Herrero-Puente , Á. González Franco
{"title":"¿Inicio de inhibidores del cotransportador de sodio-glucosa tipo 2 (iSGLT2) en pacientes con insuficiencia cardiaca aguda en urgencias?","authors":"P. Herrero-Puente , Á. González Franco","doi":"10.1016/j.rce.2026.502470","DOIUrl":"10.1016/j.rce.2026.502470","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"226 3","pages":"Article 502470"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147429085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-16DOI: 10.1016/j.rce.2026.502469
C. Burgueño-Montañes , R. Bouchikh-El Jarroudi , M. Zavaleta-Mercado , J. Galvez-Olortegui
{"title":"Metodología GRADE en los consensos y guías de práctica clínica para el manejo de la oclusión venosa retiniana","authors":"C. Burgueño-Montañes , R. Bouchikh-El Jarroudi , M. Zavaleta-Mercado , J. Galvez-Olortegui","doi":"10.1016/j.rce.2026.502469","DOIUrl":"10.1016/j.rce.2026.502469","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"226 3","pages":"Article 502469"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147429083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-16DOI: 10.1016/j.rce.2026.502474
Ò. Miró , L. Sentís , M. Carbó , E. Miró , D. Mérida , J. González del Castillo , (en representación del grupo SIESTA)
Objective
To investigate the incidence, sociodemographic characteristics, baseline status and evolution of elderly people living with Human immunodeficiency virus (HIV) infection (PLHIV) attended in Spanish hospital emergency departments (ED).
Methods
Patients included in the EDEN (Emergency Department and Elder Needs) registry, which includes all patients aged 65 or older attended in 52 Spanish EDs during 7 consecutive days in 2019, were analyzed. Two groups were constructed according to whether or not they had known HIV infection (PLHIV and non-LHIV). We collected 6 sociodemographic factors and 8 referring to the patient's baseline situation. We recorded whether the episode of ED care required hospitalization, intensive care unit (ICU) admission, prolonged ED and inpatient stay, and in-hospital mortality, as well as reconsultation to the ED, rehospitalization, and death from any cause during the 3 years after discharge. The sociodemographic and baseline characteristics and the evolution of patients in the PLHIV and non-PLHIV groups were compared.
Results
Of 25,557 patients in the EDEN registry, 78 were PLHIV (0.30%, 95% CI 0.24% to 0.38%). The annual ED frequentation rate of PLHIV and non-PVHIV was 811 and 573 per 1000 population, respectively. The sociodemographic and baseline conditions were similar between PLHIV and non-PLHIV, with only age differing (younger PLHIV). Older PLHIV had severe comorbidity (27%), some type of functional limitation (27%) and cognitive impairment (11%). The most frequent ED diagnoses in PLHIV were pneumonia or lower respiratory tract infection (11%), heart failure or cardiogenic shock (8%) and joint and axial pain (6%), and in the non-HIV group there were no new diagnoses of HIV infection. 24.4% of PLHIV were hospitalized, 27.3% had a prolonged stay in the ED, 50% had prolonged hospitalization, 7.7% had in-hospital mortality, and reconsultation to the ED, hospitalization, and death during the 3 years post-discharge were 67%, 45.6%, and 21.7%, respectively. No outcome differed between PLHIV and non-PLHIV.
Conclusion
Older PLHIV have sociodemographic and baseline characteristics like the general population, but their rate of ED visits is higher. The severity of the episodes leading to this ED consultation is similar between PLHIV and non-PLHIV and long-term follow-up also shows no differences.
目的调查西班牙医院急诊科（ED）老年人HIV感染（PLHIV）的发生率、社会人口学特征、基线状况及演变。方法分析EDEN（急诊科和老年人需求）登记处的患者，其中包括2019年连续7天在52个西班牙急诊科就诊的所有65岁及以上患者。根据是否已知HIV感染分为PLHIV和non-LHIV两组。我们收集了6个社会人口学因素和8个涉及患者基线情况的因素。我们记录了在出院后的3年内，急诊科的发作是否需要住院、重症监护病房（ICU）入院、延长急诊科和住院时间、住院死亡率、再咨询急诊科、再住院和任何原因死亡。比较PLHIV组和非PLHIV组患者的社会人口学特征和基线特征及其演变。结果在EDEN登记的25557例患者中，78例为PLHIV （0.30%, 95% CI 0.24%至0.38%）。PLHIV和非pvhiv的ED年发病率分别为811 / 1000和573 / 1000。PLHIV和非PLHIV之间的社会人口学和基线条件相似，只是年龄不同（年轻的PLHIV）。老年PLHIV患者有严重的合并症（27%），某种类型的功能限制（27%）和认知障碍（11%）。PLHIV患者中最常见的ED诊断为肺炎或下呼吸道感染（11%）、心力衰竭或心源性休克（8%）、关节和轴性疼痛（6%），而非HIV组中没有新的HIV感染诊断。24.4%的PLHIV患者住院，27.3%的患者在急诊科长时间住院，50%的患者长时间住院，7.7%的患者住院死亡，出院后3年内再诊、住院和死亡的比例分别为67%、45.6%和21.7%。PLHIV和非PLHIV之间没有结果差异。结论老年hiv患者具有与普通人群相似的社会人口学特征和基线特征，但急诊科就诊率较高。在PLHIV和非PLHIV患者中，导致ED会诊的发作的严重程度相似，长期随访也没有差异。
{"title":"Consultas en urgencias de los pacientes mayores que viven con VIH: una aproximación a partir del registro EDEN","authors":"Ò. Miró , L. Sentís , M. Carbó , E. Miró , D. Mérida , J. González del Castillo , (en representación del grupo SIESTA)","doi":"10.1016/j.rce.2026.502474","DOIUrl":"10.1016/j.rce.2026.502474","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the incidence, sociodemographic characteristics, baseline status and evolution of elderly people living with Human immunodeficiency virus (HIV) infection (PLHIV) attended in Spanish hospital emergency departments (ED).</div></div><div><h3>Methods</h3><div>Patients included in the EDEN (Emergency Department and Elder Needs) registry, which includes all patients aged 65 or older attended in 52 Spanish EDs during 7 consecutive days in 2019, were analyzed. Two groups were constructed according to whether or not they had known HIV infection (PLHIV and non-LHIV). We collected 6 sociodemographic factors and 8 referring to the patient's baseline situation. We recorded whether the episode of ED care required hospitalization, intensive care unit (ICU) admission, prolonged ED and inpatient stay, and in-hospital mortality, as well as reconsultation to the ED, rehospitalization, and death from any cause during the 3 years after discharge. The sociodemographic and baseline characteristics and the evolution of patients in the PLHIV and non-PLHIV groups were compared.</div></div><div><h3>Results</h3><div>Of 25,557 patients in the EDEN registry, 78 were PLHIV (0.30%, 95% CI 0.24% to 0.38%). The annual ED frequentation rate of PLHIV and non-PVHIV was 811 and 573 per 1000 population, respectively. The sociodemographic and baseline conditions were similar between PLHIV and non-PLHIV, with only age differing (younger PLHIV). Older PLHIV had severe comorbidity (27%), some type of functional limitation (27%) and cognitive impairment (11%). The most frequent ED diagnoses in PLHIV were pneumonia or lower respiratory tract infection (11%), heart failure or cardiogenic <em>shock</em> (8%) and joint and axial pain (6%), and in the non-HIV group there were no new diagnoses of HIV infection. 24.4% of PLHIV were hospitalized, 27.3% had a prolonged stay in the ED, 50% had prolonged hospitalization, 7.7% had in-hospital mortality, and reconsultation to the ED, hospitalization, and death during the 3 years post-discharge were 67%, 45.6%, and 21.7%, respectively. No outcome differed between PLHIV and non-PLHIV.</div></div><div><h3>Conclusion</h3><div>Older PLHIV have sociodemographic and baseline characteristics like the general population, but their rate of ED visits is higher. The severity of the episodes leading to this ED consultation is similar between PLHIV and non-PLHIV and long-term follow-up also shows no differences.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"226 3","pages":"Article 502474"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147428022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-28DOI: 10.1016/j.rce.2026.502486
W.-Q. Zheng , S. Bielsa , Y. Niu , J.-X. Wen , L. Yan , Z.-D. Hu , J.M. Porcel
Objective
This study aimed to investigate the effects of age on the sensitivity, specificity, and accuracy of Light's criteria to differentiate exudative from transudative pleural effusion.
Methods
A testing cohort from China and a validation cohort from Spain were used for data analysis. The testing cohort included 302 patients (59 transudates and 243 exudates) with undiagnosed pleural effusion. The validation cohort comprised 400 patients (200 transudates and 200 exudates) divided into two groups according to age (200 patients aged 50-65 years and 200 patients aged 80-95 years). The effects of age on the sensitivity, specificity, and accuracy of Light's criteria were determined by sampling patients with different age limits.
Results
In the testing cohort, the sensitivity and specificity of Light's criteria for exudate were 0.91 and 0.73, respectively. In the validation cohort, the sensitivity was 0.99 and 0.97, and the specificity of Light's criteria for exudate was 0.73 and 0.68, respectively, by age group. The diagnostic accuracy metrics (sensitivity, specificity, and accuracy) of Light's criteria and its items tended to decrease with age.
Conclusion
Age should be considered when interpreting the Light's criteria.
{"title":"El efecto de la edad en la precisión de los criterios de Light","authors":"W.-Q. Zheng , S. Bielsa , Y. Niu , J.-X. Wen , L. Yan , Z.-D. Hu , J.M. Porcel","doi":"10.1016/j.rce.2026.502486","DOIUrl":"10.1016/j.rce.2026.502486","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to investigate the effects of age on the sensitivity, specificity, and accuracy of Light's criteria to differentiate exudative from transudative pleural effusion.</div></div><div><h3>Methods</h3><div>A testing cohort from China and a validation cohort from Spain were used for data analysis. The testing cohort included 302 patients (59 transudates and 243 exudates) with undiagnosed pleural effusion. The validation cohort comprised 400 patients (200 transudates and 200 exudates) divided into two groups according to age (200 patients aged 50-65<!--> <!-->years and 200 patients aged 80-95<!--> <!-->years). The effects of age on the sensitivity, specificity, and accuracy of Light's criteria were determined by sampling patients with different age limits.</div></div><div><h3>Results</h3><div>In the testing cohort, the sensitivity and specificity of Light's criteria for exudate were 0.91 and 0.73, respectively. In the validation cohort, the sensitivity was 0.99 and 0.97, and the specificity of Light's criteria for exudate was 0.73 and 0.68, respectively, by age group. The diagnostic accuracy metrics (sensitivity, specificity, and accuracy) of Light's criteria and its items tended to decrease with age.</div></div><div><h3>Conclusion</h3><div>Age should be considered when interpreting the Light's criteria.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"226 3","pages":"Article 502486"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147429076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-20DOI: 10.1016/j.rce.2026.502482
J. Pagán Escribano
{"title":"Respuesta a: Metodología GRADE en los consensos y guías de práctica clínica para el manejo de la oclusión venosa retiniana","authors":"J. Pagán Escribano","doi":"10.1016/j.rce.2026.502482","DOIUrl":"10.1016/j.rce.2026.502482","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"226 3","pages":"Article 502482"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147429081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-16DOI: 10.1016/j.rce.2026.502472
J. Cabañas Morafraile , L. Serrano Martín , E. de Rafael González , A. Julián-Jiménez , en nombre del grupo URGEN-LABQMIC del CHUT del Instituto de Investigación Sanitaria de Castilla La Mancha (IDISCAM)
{"title":"La procalcitonina y la región medial de la proadrenomedulina (MR-proADM) podrían ayudar a hacer más segura la hospitalización a domicilio de los pacientes atendidos en urgencias por sospecha de infección","authors":"J. Cabañas Morafraile , L. Serrano Martín , E. de Rafael González , A. Julián-Jiménez , en nombre del grupo URGEN-LABQMIC del CHUT del Instituto de Investigación Sanitaria de Castilla La Mancha (IDISCAM)","doi":"10.1016/j.rce.2026.502472","DOIUrl":"10.1016/j.rce.2026.502472","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"226 3","pages":"Article 502472"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147428020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-18DOI: 10.1016/j.rce.2026.502471
J.M. Fernández Rodríguez , M.B. Alonso-Ortíz , J. Casado Cerrada , D. Chivite Guillen , P. Cubo Romano , R. García Alonso , A. Lorenzo Almorós , J.P. Miramontes-González , L. Soler Rangel , J. Pérez-Silvestre
Heart failure (HF) is associated with high morbidity and mortality. HF with preserved left ventricular ejection fraction (HF-pEF) accounts for up to 50% of all HF cases, being the most common in elderly patients. In addition, these subjects frequently present other comorbidities. For all these reasons, the diagnosis of patients with HF-pEF is complex and requires a careful approach. In addition, there are «secondary» or HF-pEF forms that must also be discarded. The treatment of HF-pEF has evolved very significantly in recent years due to evidence from clinical trials. Until a few years ago, the management was based on the treatment of congestive symptoms with diuretics and comorbidities, to this was added the indication of treatment with SGLT2 inhibitors, after being shown to reduce hospitalizations due to HF, and more recently new evidence of clinical benefit with other drugs such as finerenone, semaglutide or tirzepatide has been published. All this makes it necessary to update the recommendations regarding the management of patients with HF-pEF.
{"title":"Insuficiencia cardíaca con fracción de eyección preservada: actualización en estrategias diagnósticas y terapéuticas. Documento de consenso de la SEMI","authors":"J.M. Fernández Rodríguez , M.B. Alonso-Ortíz , J. Casado Cerrada , D. Chivite Guillen , P. Cubo Romano , R. García Alonso , A. Lorenzo Almorós , J.P. Miramontes-González , L. Soler Rangel , J. Pérez-Silvestre","doi":"10.1016/j.rce.2026.502471","DOIUrl":"10.1016/j.rce.2026.502471","url":null,"abstract":"<div><div>Heart failure (HF) is associated with high morbidity and mortality. HF with preserved left ventricular ejection fraction (HF-pEF) accounts for up to 50% of all HF cases, being the most common in elderly patients. In addition, these subjects frequently present other comorbidities. For all these reasons, the diagnosis of patients with HF-pEF is complex and requires a careful approach. In addition, there are «secondary» or HF-pEF forms that must also be discarded. The treatment of HF-pEF has evolved very significantly in recent years due to evidence from clinical trials. Until a few years ago, the management was based on the treatment of congestive symptoms with diuretics and comorbidities, to this was added the indication of treatment with SGLT2 inhibitors, after being shown to reduce hospitalizations due to HF, and more recently new evidence of clinical benefit with other drugs such as finerenone, semaglutide or tirzepatide has been published. All this makes it necessary to update the recommendations regarding the management of patients with HF-pEF.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"226 3","pages":"Article 502471"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147428017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号